Lamictal for Bipolar: What It Protects Against and What It Doesn't
Last updated November 5, 2026
Key Takeaways
- Lamictal (lamotrigine) is FDA-approved to delay new mood episodes in bipolar I disorder. It isn't recommended for treating an active manic or mixed episode.
- In 18-month trials, lamotrigine's clearest strength was preventing depressive episodes, while lithium was stronger against mania.
- The dose climbs slowly over about six weeks because starting too fast raises the risk of a rare but serious rash.
- Valproate, carbamazepine, and estrogen-containing birth control can change lamotrigine levels, so tell your prescriber before starting or stopping them.
If you live with bipolar disorder, you may know the lows better than the highs. They can drag on, crowd out sleep and work, and make it hard to picture feeling steady again. Lamictal is one of the medications most closely tied to protecting against those lows, and knowing exactly what it does and doesn’t do shapes what you can expect from it.
Lamotrigine, the active drug in Lamictal, was first used to treat epilepsy, a condition driven by bursts of excess electrical activity in the brain. In lab studies, it blocks voltage-sensitive sodium channels, which steadies nerve cell membranes and reduces the release of glutamate, the brain’s main excitatory messenger. The Lamictal prescribing information notes that how this translates to bipolar disorder hasn’t been established. What the trials do show, with real precision, is which kinds of episodes it delays.
For decades, the standard long-term treatment for bipolar disorder has been lithium. It’s a mood stabilizer with a long track record, and in the same 18-month trials that tested lamotrigine, lithium was the stronger shield against mania. The 2018 CANMAT and ISBD guidelines still rank lithium among the first-line maintenance treatments. The results are real, and the science is well-established.
But protection against highs doesn’t automatically cover the lows, and at Siggy we’d rather match a medication to the episodes you actually live with than default to one drug for everyone.
Lamictal is an anticonvulsant mood stabilizer that delays new mood episodes, with its clearest effect on bipolar depression. This guide covers what it’s approved for, how well it works, why it starts so slowly, the side effects worth knowing, and who it fits best. That role was earned in trials that tracked which episodes it prevents, so it rests on evidence.
What This Page Covers
- What Is Lamictal Approved for in Bipolar Disorder?
- How Well Does Lamictal Prevent Bipolar Depression?
- Does Lamictal Help During a Depressive Episode?
- How Does Lamictal Compare With Lithium?
- Why Does Lamictal Start So Slowly?
- What Side Effects Should You Watch For?
- What Can Change Your Lamictal Levels?
- Who Is Lamictal a Good Fit For?
- How Siggy Fits In
- The Bottom Line on Lamictal for Bipolar
- Start Your Anonymous Intake
What Is Lamictal Approved for in Bipolar Disorder?
The FDA approved Lamictal for maintenance treatment of bipolar I disorder. Its job is to delay the next mood episode, whether depression, mania, hypomania, or a mixed episode, in people who have already been treated for an acute episode with standard therapy.
The label is just as clear about the limits. Lamictal isn’t recommended for treating an active manic or mixed episode, and its effectiveness for any acute mood episode hasn’t been established. In practice, that means Lamictal is usually started once you’re stable, or alongside other treatment, to keep the next episode from arriving.
Clinicians also use it for bipolar depression. The CANMAT and ISBD guidelines list lamotrigine as a first-line option for bipolar I depression, alone or added to other treatment, and as a first-line maintenance treatment. Using it for an active depressive episode is off-label in the U.S.
How Well Does Lamictal Prevent Bipolar Depression?
Two 18-month trials form the backbone of the evidence. Adults with bipolar I disorder were stabilized, then randomly assigned to lamotrigine, lithium, or placebo, and followed to see how long they went before needing treatment for a new episode. Because everyone had already stabilized, the results describe prevention, not rescue from an active episode.
In the trial of recently depressed patients, 57% of people on lamotrigine went a full year without needing treatment for depression, compared with 46% on lithium and 45% on placebo. Participants needed intervention for depression nearly three times as often as for mania, which is why depression protection matters so much. A companion trial in manic patients reached the same overall conclusion: both drugs beat placebo, and lamotrigine’s particular strength was preventing depression.
Newer analyses have held up. A 2025 meta-analysis of 24 trials found lamotrigine lowered the risk of depressive symptoms returning by about 22% compared with placebo, though it wasn’t better than lithium.
Does Lamictal Help During a Depressive Episode?
This is where the evidence gets more modest. Individual trials of lamotrigine for acute bipolar depression produced mixed results. When researchers pooled data from 1,072 participants in five of them in a 2009 pooled meta-analysis, lamotrigine did outperform placebo: about 11 people needed treatment for one extra person to respond, and the benefit showed up mainly in people whose depression was more severe at the start.
The 2025 meta-analysis described the acute effect as small. Lamotrigine also needs weeks of slow dose increases before it reaches a typical dose, so it’s rarely the fastest route out of a severe low. When you need relief sooner, your prescriber may pair it with another medication or choose a different first step.
How Does Lamictal Compare With Lithium?
Lamictal and lithium are often framed as alternatives, but the trials suggest they guard different poles of the illness. Here’s how they compared in a pooled analysis of 638 patients and a weight analysis of those trials.
| Treatment | Median Days to Any New Episode | Stronger Protection Against | Weight Change at 1 Year |
|---|---|---|---|
| Lamotrigine | 197 | Depression | Down 1.2 kg |
| Lithium | 184 | Mania | Up 2.2 kg |
| Placebo | 86 | Not applicable | Up 0.2 kg |
Both drugs roughly doubled the time before people needed treatment for a new episode. The weight difference between lamotrigine and placebo wasn’t statistically significant, so the fair summary is that Lamictal tends to be weight-neutral. Lithium also caused more diarrhea and tremor in the pooled data.
Because the two cover different ground, prescribers sometimes combine them. Our guide to lithium for bipolar covers the other half of that picture.
Why Does Lamictal Start So Slowly?
Lamictal’s dose climbs gradually over about six weeks, and the reason is rash. The prescribing information states that exceeding the recommended starting dose or the pace of increases raises the risk of a serious, potentially life-threatening rash. Here’s the label’s schedule for adults with bipolar disorder.
| Week | Typical Schedule | If Taking Valproate | If Taking Carbamazepine, No Valproate |
|---|---|---|---|
| Weeks 1 and 2 | 25 mg daily | 25 mg every other day | 50 mg daily |
| Weeks 3 and 4 | 50 mg daily | 25 mg daily | 100 mg daily |
| Week 5 | 100 mg daily | 50 mg daily | 200 mg daily |
| Week 6 | 200 mg daily | 100 mg daily | 300 mg daily |
| Week 7 | 200 mg daily | 100 mg daily | Up to 400 mg daily |
The last column also applies to phenytoin, phenobarbital, primidone, and rifampin, but only when valproate isn’t part of the regimen. The target dose depends on the column: 200 mg a day on the typical schedule, 100 mg with valproate, and 400 mg with those enzyme-inducing drugs. For people taking Lamictal without them, the label notes that 400 mg worked no better than 200 mg in trials, so it doesn’t recommend going above 200 mg. If you stop Lamictal for long enough, generally more than five half-lives of the drug, the label recommends restarting at the beginning of the schedule. Your prescriber sets your exact plan, and our Lamictal dosage guide goes deeper.
What Side Effects Should You Watch For?
Most side effects are mild. In the bipolar trials, the ones reported by more than 5% of adults were nausea, trouble sleeping, sleepiness, back pain, fatigue, rash, runny nose, stomach pain, and dry mouth.
The side effect that matters most is serious rash, including Stevens-Johnson syndrome. In the bipolar and mood disorder trials, serious rash occurred in 0.08% of adults who started lamotrigine on its own and 0.13% of those who added it to other medication. Nearly all life-threatening rashes appear within the first 2 to 8 weeks. Risk rises with valproate, with dosing faster than recommended, and with a genetic marker called HLA-B*1502, which has been linked to higher risk in people of certain Asian ancestries. Because there’s no reliable way to tell early which rash will turn serious, the label advises stopping Lamictal at the first sign of rash unless it’s clearly unrelated to the drug.
If you notice a rash, hives, fever, swollen glands, or mouth sores, contact your prescriber the same day. If symptoms are severe or spreading fast, call 911.
The label also lists rarer serious risks: an immune reaction called hemophagocytic lymphohistiocytosis (HLH), heart rhythm problems in people with significant structural heart disease, and the warning about suicidal thoughts that applies to all antiseizure medications. If you have thoughts of harming yourself, call 911 or call or text 988. Our Lamictal side effects guide covers each risk in more detail.
What Can Change Your Lamictal Levels?
Your liver clears lamotrigine through a process called glucuronidation, so medicines that speed it up or slow it down change how much reaches your bloodstream. The label’s interaction table lists the big ones:
- Valproate (Depakote) more than doubles lamotrigine levels, which is why doses are cut roughly in half.
- Carbamazepine, phenytoin, phenobarbital, primidone, and rifampin lower levels by about 40%.
- Estrogen-containing birth control pills lower levels by about 50%, and levels can nearly double by the end of the pill-free week.
- Pregnancy can lower levels, which typically return to baseline after delivery.
Progestin-only pills don’t appear to affect levels. Starting or stopping any of the medicines above is a reason to talk with your prescriber first, because your dose may need to change.
Who Is Lamictal a Good Fit For?
Lamictal tends to make the most sense when depression is the dominant pattern in your bipolar disorder and you’re stable enough to wait through a slow start. It’s also worth discussing if weight gain or tremor from another mood stabilizer has made that medication hard to stay on.
It’s usually not the right tool for:
- An active manic or mixed episode
- Situations that call for fast symptom control
- A past serious rash on lamotrigine
- Significant structural heart disease, where risks need careful weighing
A 2021 systematic review found little strong evidence for lamotrigine in acute mania or rapid-cycling bipolar disorder, and few controlled trials in bipolar II. Before starting, expect your prescriber to review your mood history, other medications and birth control, heart history, and any past rashes. If you’re pregnant or planning to be, the label notes that pregnancy registries haven’t found a higher overall rate of major birth defects than in the general population, but dosing often needs adjustment, so plan it together.
How Siggy Fits In
Lamictal asks for patience: about six weeks of careful dose steps, a close eye on your skin in the first two months, and months more before you know how well it’s protecting you. That works best with a prescriber who can see your whole mood history, highs included.
Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including bipolar disorder, and a prescriber can talk with you about whether Lamictal fits. Siggy can also help earlier in the story. If you’re not sure whether your lows are depression or bipolar depression, the free, anonymous intake, with no name or email required, asks about your highs as carefully as your lows. A licensed prescriber reviews your intake before anything is prescribed, and you get a summary you can keep and share with whoever manages your care.
This article is for education and isn’t a substitute for care from a licensed clinician.
The Bottom Line on Lamictal for Bipolar
Lamictal is one of the better-studied ways to keep bipolar depression from coming back, and it does so without the weight gain common to many alternatives. It’s weaker against mania and slow to start, so it often works best as one part of a plan, sometimes alongside lithium or another mood stabilizer. If you’re weighing your options, our guide to bipolar depression treatment compares the medications used when the lows are the hardest part.
Start Your Anonymous Intake
If you’re in crisis or thinking about harming yourself, call 911 or call or text 988 first. If you’re not sure whether your lows are depression or bipolar depression and you want a licensed prescriber to look at your whole mood history, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed. Your summary is yours to keep and share with whoever manages your care next.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
What is Lamictal used for in bipolar disorder?
Lamictal is used to delay new mood episodes in people with bipolar I disorder after an acute episode has been treated. Its FDA approval covers maintenance treatment, and its clearest benefit in trials was preventing depressive episodes. Prescribers also use it off-label for bipolar depression.
Does Lamictal work for mania?
Lamictal is not recommended for treating an active manic or mixed episode, and its effectiveness for acute mood episodes hasn't been established. In long-term trials, lithium was the stronger option for preventing new manic episodes, while lamotrigine's clearest benefit was preventing depression.
How long does it take Lamictal to work for bipolar disorder?
Reaching the usual target dose of 200 mg a day takes about six weeks because the dose has to rise slowly to lower rash risk. Because Lamictal's main job is preventing future episodes, its benefit is usually judged over months of stable treatment rather than days.
Does Lamictal cause weight gain?
Lamictal is generally weight-neutral. In an analysis of two 18-month bipolar trials, average weight at one year changed by minus 1.2 kg on lamotrigine, plus 0.2 kg on placebo, and plus 2.2 kg on lithium, and the difference between lamotrigine and placebo wasn't statistically significant.
When should I worry about a rash on Lamictal?
Any new rash while taking Lamictal, especially in the first 2 to 8 weeks, is a reason to contact your prescriber the same day. The prescribing information advises stopping Lamictal at the first sign of rash unless it's clearly unrelated, because early rashes can't be reliably sorted into harmless and serious. Call 911 if a rash spreads quickly or comes with fever or mouth sores.
Can you take Lamictal with lithium?
Yes, Lamictal and lithium can be taken together, and prescribers sometimes combine them because lamotrigine is stronger against depression and lithium is stronger against mania. According to the prescribing information, lamotrigine did not change lithium's blood levels in healthy volunteers.
Sources
- GlaxoSmithKline. Lamictal (lamotrigine) prescribing information. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov
- Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. 2018;20(2):97-170. doi:10.1111/bdi.12609
- Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry. 2003;64(9):1013-1024. doi:10.4088/jcp.v64n0906
- Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry. 2003;60(4):392-400. doi:10.1001/archpsyc.60.4.392
- Arnone D, Östlundh L, Mosa M, et al. Efficacy of lamotrigine in the treatment of unipolar and bipolar depression: meta-analysis of acute and maintenance randomised controlled trials. Pharmaceuticals. 2025;18(10):1590. doi:10.3390/ph18101590
- Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. British Journal of Psychiatry. 2009;194(1):4-9. doi:10.1192/bjp.bp.107.048504
- Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. Journal of Clinical Psychiatry. 2004;65(3):432-441. doi:10.4088/jcp.v65n0321
- Sachs G, Bowden C, Calabrese JR, et al. Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. Bipolar Disorders. 2006;8(2):175-181. doi:10.1111/j.1399-5618.2006.00308.x
- Besag FMC, Vasey MJ, Sharma AN, Lam ICH. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Therapeutic Advances in Psychopharmacology. 2021;11:20451253211045870. doi:10.1177/20451253211045870